Citi has maintained a 'buy' rating on PB Fintech, setting a target price of Rs 1,925 per share, reflecting an 18% upside potential. The firm cites strong momentum in retail health and protection segments, alongside improving contribution and EBITDA margins, as key growth catalysts. Following the announcement, PB Fintech shares rose over 4%, trading at Rs 1,680.4.